Taupenot, L <br/><br/>
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonism.  [electronic resource] 

 -  Regulatory peptides  Nov 2000 
 - 9-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0167-0115 
<br/><br/><label>Standard No.: </label>10.1016/s0167-0115(00)00135-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Binding, Competitive<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacokinetics<br/>Cattle<br/>Cell Membrane--physiology<br/>Chromaffin Cells--drug effects<br/>Chromogranin A<br/>Chromogranins--pharmacokinetics<br/>Electric Organ--physiology<br/>Humans<br/>Kinetics<br/>Molecular Sequence Data<br/>Nicotinic Agonists--pharmacokinetics<br/>PC12 Cells<br/>Peptide Fragments--pharmacokinetics<br/>Pyridines--pharmacokinetics<br/>Rats<br/>Receptors, Nicotinic--drug effects<br/>Torpedo